ClinicalTrials.Veeva

Menu

Mechanisms for Organ Dysfunction in Covid-19 (UMODCOVID19)

U

Uppsala University

Status

Completed

Conditions

COVID-19
Organ Dysfunction Syndrome, Multiple
Organ Dysfunction Syndrome Sepsis
Acute Kidney Injury
Acute Respiratory Distress Syndrome
Septic Shock

Study type

Observational

Funder types

Other

Identifiers

NCT04316884
EPN 2017/043 Covid19

Details and patient eligibility

About

The study aims to investigate organ dysfunction and biomarkers in patients with suspected or verified COVID-19 during intensive care at Uppsala University Hospital.

Full description

Consenting patients with suspected or verified SARS-COV-2 infection, COVID-19, will undergo daily blood, urine and sputum sampling during their stay in intensive care. Data on organ dysfunction will be collected through the electronic patient journal and electronic patient data management system. The collected samples will be analysed for a panel of potential biomarkers that will be correlated to organ dysfunction and clinical outcome.

Enrollment

380 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Admitted to intensive care
  • suspected or verified COVID-19

Exclusion criteria

  • Pregnancy or breastfeeding
  • Under-age

Trial design

380 participants in 1 patient group

COVID-19
Description:
Patients with suspected or verified COVID-19 admitted to intensive care at Uppsala University Hospital

Trial contacts and locations

1

Loading...

Central trial contact

Sara Bülow Anderberg, MD.; Robert Frithiof, MD. PhD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems